University of California San Francisco
Give to UCSF
UCSF has received a challenge gift of $20 million from the Sandler Foundation that will provide major support for the university’s groundbreaking research and clinical care efforts regarding neurological diseases.
Chronic pain, by definition, is difficult to manage, but a new study by UCSF scientists shows how a cell therapy might one day be used not only to quell some common types of persistent and difficult-to-treat pain, but also to cure the conditions that give rise to them.
<p>Construction of UCSF Medical Center at Mission Bay is well underway, with the building’s exterior panels, glass, and interior studs being installed.</p>
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
UCSF scientists have shown that a key brain structure in the Bengalese finch acts as a learning hub, receiving information that helps to improve its song, a finding which may lead to new ways to treat neurological disorders that impair movement such as Parkinson’s disease.
To celebrate nearly a quarter-century of advances in hematology and transplantation, UCSF is holding a reunion of patients from the UCSF Medical Center who have undergone bone marrow transplants.
Viral hepatitis chronically infects between 3.5 and 5.2 million people in the U.S. – more than 30,000 in San Francisco, alone – but only about one in three people who are infected know it, according to a report by the U.S. Department of Health and Human Services.
What is the connection, if any, between sudden cardiac death and people with HIV/AIDS? And can that knowledge help prolong their lives?